Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach
Cancer Prev Res Redman et al.
1: 174
Finasteride and Prostate Cancer: New York Times Article
The following articles, published Online First on May 18, 2008 in Cancer Prevention Research, present data from the Prostate Cancer Prevention Trial indicating that finasteride reduces the risk of prostate cancer. Presented in the Plenary Session of the 2008 Annual Meeting of the American Urological Association, the studies were featured in the June 15, 2008 issue of The New York Times.
New York Times Article:
“New Take on a Prostate Drug, and a New Debate” (June 15, 2008)
Perspective
High-Grade Prostate Cancer and the Prostate Cancer Prevention Trial
Christopher J. Logothetis and Paul F. Schellhammer
Articles
Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach
Mary W. Redman, Catherine M. Tangen, Phyllis J. Goodman, M. Scott Lucia, Charles A. Coltman Jr., and Ian M. Thompson
Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
M. Scott Lucia, Amy K. Darke, Phyllis J. Goodman, Francisco G. La Rosa, Howard L. Parnes, Leslie G. Ford, Charles A. Coltman Jr., and Ian M. Thompson
Estimating Rates of True High-Grade Disease in the Prostate Cancer Prevention Trial
Paul Pinsky, Howard Parnes, and Leslie Ford
